Skip to main content
SpringerLink
Log in
Book cover

Breast Cancer pp 119–151Cite as

Palgrave Macmillan

Profits from Pain: The Political Economy of Breast Cancer

  • Chapter

Abstract

AdWeek describes breast cancer as a “dream cause … it’s the feminist issue without politics … without controversy” (Goldman 1997:70). Politicians may have adopted breast cancer issues to straddle the gender divide, but, in reality, breast cancer is an illness that is steeped in controversy. Breast cancer’s visibility, accompanied by a bonanza of economic and political possibilities, has made the illness the province of entrepreneurs. Breast cancer has become a source of economic gain.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrews, Charles. 1995. Profit Fever—The Drive to Corporatize Health Care and How to Stop It. Monroe, Maine: Common Courage Press.

    Google Scholar 

  • Angier, Natalie. 1994. “Vexing Pursuit of Breast Cancer Gene.” New York Times (July 12) C1.

    Google Scholar 

  • Arnot, Bob. 1998. The Breast Cancer Prevention Diet—The Powerful Foods, Supplements and Drugs That Combat Breast Cancer. Boston: Little, Brown.

    Google Scholar 

  • Bailar, John C., III. 1976. “Mammography: A Contrary View.” Annals of Internal Medicine 84:77–84.

    Article  Google Scholar 

  • Bailar, John C., III and Elaine M. Smith. 1986. “Progress Against Cancer?” New England Journal of Medicine 314:1226–32.

    Article  Google Scholar 

  • Berry, Donald A. 1998. “Benefits and Risks of Screening Mammography for Women in Their Forties: A Statistical Appraisal.” Journal of the National Cancer Institute 90:1431–39.

    Article  Google Scholar 

  • Brenner, Barbara A. 1997. “The Government’s Numbers Game.” Breast Cancer Action Newsletter (December 1996/January 1997) 1.

    Google Scholar 

  • Brenner, Barbara A. 1997. “The Future Is Now.” Breast Cancer ActionNewsletter (Feb./March) 2, 9.

    Google Scholar 

  • Brown, Jennifer. 1999. “Debunking Health Book Hype.” Self (June) 84–85.

    Google Scholar 

  • Brown, M. L., L. G. Kessler, and F. G. Rueter. 1990. “Is the Supply of Mammography Machines Outstripping Need and Demand?” Annals of Internal Medicine 113:547–52.

    Article  Google Scholar 

  • Butler, Declan, and Diane Gershon. 1994. “Breast Cancer Discovery Sparks New Debate on Patenting Human Genes.” Nature 371:271–72.

    Google Scholar 

  • “Cancer. It’s a War.” 1999. New Yorker (February 22 and March 1) 61.

    Google Scholar 

  • Cairns, John. 1997. Matters of Life and Death—Perspectives on Public Health, Molecular Biology, Cancer, and the Prospects for the Human Race. Princeton: Princeton University Press.

    Google Scholar 

  • Cimons, Marlene. 1998. “Breast Cancer Study Offers Hope but No Easy Answers.” Los Angeles Times (April 7) A1.

    Google Scholar 

  • Cunningham, George C. 1997. “A Public Health Perspective on the Control of Predictive Screening for Breast Cancer.” Health Matrix 7:31–48.

    Google Scholar 

  • Derber, Charles. 1998. Corporate Nation. New York: St. Martin’s Press.

    Google Scholar 

  • DiLorenzo, James T. and Thomas J. Bennett 1994. Unhealthy Charities—Hazardous to Your Health and Wealth. New York: Basic Books.

    Google Scholar 

  • ECRI. 1996. “High-Dose Chemotherapy with Bone Marrow Transplant for Metastatic Breast Cancer—Patient Reference Guide.” ECRI, Plymouth Meeting, Pa.

    Google Scholar 

  • Eisen, Andrea, and Barbara L. Weber. 1999. “Prophylactic Mastectomy—The Price of Fear.” New England Journal of Medicine 340:137–38.

    Article  Google Scholar 

  • Elmore, Joann G., Carolyn K. Wells, C. H. Lee, Deborah H. Howard, and Alvan R. Feinstein. 1994. “Variability in Radiologists’ Interpretations of Mammograms.” New England Journal of Medicine 331:1493–99.

    Article  Google Scholar 

  • Elmore, Joann G., Mary B. Barton, Victoria M. Moceri, Sarah Polk, Philip J. Arena, and Susan W. Fletcher. 1998. “Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations.” New England Journal of Medicine 338:1089–96.

    Article  Google Scholar 

  • Ernster, Virginia L. 1997. “Mammography Screening for Women Aged 40 through 49—A Guidelines Saga and a Clarion Call for Informed Decision Making.” American Journal of Public Health 87:1103–5.

    Article  Google Scholar 

  • Ernster, Virginia L., John Barclay, Karla Kerlikowske, Deborah Grady, and I. Craig Henderson. 1996. “Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast.” Journal of the American Medical Association 275:913–18.

    Article  Google Scholar 

  • Fackelmann, K. A. 1993. “Weighing Risks, Benefits of Mammography.” Science News (October 23) 262.

    Google Scholar 

  • Feig, Stephen A. 1996. “Strategies for Improving Sensitivity of Screening Mammography for Women Aged 40 to 49 Years.” Journal of the American Medical Association 276:73–74.

    Article  Google Scholar 

  • Fellers, Li. 1998. “Taxol Is One of the Best Cancer Drugs Ever Discovered by the Federal Government. Why Is It Beyond Some Patients’ Reach?” Washington Post (March 31) W10.

    Google Scholar 

  • Fugh-Berman, Adriane, and Samuel Epstein. 1992. “Tamoxifen: Disease Prevention or Disease Substitution?” Lancet 340:1143–45.

    Article  Google Scholar 

  • Garaghan, Helen. 1994. “NIH Files Counter-Patent in Breast Cancer Gene Dispute.” Nature 372:118.

    Google Scholar 

  • Gofman, John W. 1995. Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of this Disease. San Francisco: Committee for Nuclear Responsibility.

    Google Scholar 

  • Goldman, D. 1997. “Illness as Metaphor.” AdWeek (November 3) 70.

    Google Scholar 

  • Goldstein, Amy. 1999. “More Americans Lack Health Coverage.” San Francisco Chronicle (October 4)A1.

    Google Scholar 

  • Gordon, Nancy P., Thomas G. Rundall, and Laurence Parker. 1998. “Type of Health Care Coverage and the Likelihood of Being Screened for Cancer.” Medical Care 36(5):636–45.

    Article  Google Scholar 

  • Greenberg, Daniel S. 1977. “X-Ray Mammography: Silent Treatment for a Troublesome Report.” New England Journal of Medicine 296:1015–16.

    Article  Google Scholar 

  • Groopman, Jerome 1998. “A Healing Hell.” The New Yorker (October 19) 34–39.

    Google Scholar 

  • Hartmann, Lynn C., Daniel J. Schaid, John E. Woods, Thomas P. Crotty, Jeffrey L. Myers, P. G. Arnold, Paul M. Pety, Thomas A. Sellers, Joanne L. Johnson, Shannon K. McDonnell, Marlene H. Frost, and Robert B. Jenkins. 1999. “Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer.” New England Journal of Medicine 340:77–84.

    Article  Google Scholar 

  • Hightower, Jim. 1997. There’s Nothing in the Middle of the Road but Yellow Stripes and Dead Armadillos. New York: HarperCollins.

    Google Scholar 

  • Høyer, Annette Pernille, Philippe Grandjean, Torben Jørgensen, John W. Brock, and Helle Bøggild Hartvig. 1998. “Organochlorine Exposure and Risk of Breast Cancer.” Lancet 352:1816–20.

    Article  Google Scholar 

  • Hubbard, Ruth. 1995. Profitable Promises. Monroe, Maine: Common Courage Press.

    Google Scholar 

  • Hunter, David J., Susan E. Hankinson, Francine Laden, Graham A. Colditz, JoAnn E. Manson, Walter C. Willett, Frank E. Speizer, and Mary S. Wolff. 1997. “Plasma Organochlorine Levels and Risk of Breast Cancer.” New England Journal of Medicine 18:1253–58.

    Article  Google Scholar 

  • Jaggar, Sarah F. 1996. “Health Insurance: Coverage of Autologous Bone Marrow Transplant for Breast Cancer.” General Accounting Office, Washington, D.C.

    Google Scholar 

  • John, Lauren 1999. “High-priced Taxol Becoming First-line Breast Cancer Drug.” Breast Cancer Action Newsletter (April/May) 1.

    Google Scholar 

  • “Joy at Increase in Mammograms.” 1997. San Francisco Chronicle (October 10) A4.

    Google Scholar 

  • Kahn, Patricia. 1996. “Coming to Grips with Genes and Risk.” Science 274:496–98.

    Article  Google Scholar 

  • Kealey, Maura. 1999. “Drug Industry Takes Aim at Medicare and Consumers.” Public Citizen News (January/February) 5.

    Google Scholar 

  • Kelly, Patricia T. 1996. “Cancer Risk Information Services: Promise and Pitfalls.” Breast Journal 2:233–37.

    Article  Google Scholar 

  • Kelly, Susan E. and Barbara A. Koenig. 1998. “‘Rescue’ Technologies Following High-Dose Chemotherapy for Breast Cancer: How Social Context Shapes the Assessment of Innovative, Aggressive, and Lifesaving Medical Technologies.” Pp. 126–51 in Getting Doctors to Listen—Ethics and Outcomes Data in Context, ed. P.J. Boyle. Washington, D.C.: Georgetown University Press.

    Google Scholar 

  • Kerlikowske, Karla, Deborah Grady, John Barclay, Steven D. Frankel, Steven H. Ominsky, Edward A. Sickles, and Virginia Ernster. 1998. “Variability and Accuracy in Mammographic Interpretation Using the American College of Radiology Breast Imaging Reporting and Data System.” Journal of the National Cancer Institute 90:1801–9.

    Article  Google Scholar 

  • Kerlikowske, Karla, Deborah Grady, J. Barclay, Edward A. Sickles, A. Eaton, and Virginia Ernster. 1993. “Positive Predictive Value of Screening Mammography by Age and Family History of Breast Cancer.” Journal of the American Medical Association 270:2444–50.

    Article  Google Scholar 

  • Kerlikowske, Karla, Deborah Grady, John Barclay, Edward A. Sickles, and Virginia Ernster. 1996. “Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography.” Journal of the American Medical Association 276:33–38.

    Article  Google Scholar 

  • Krieger, Nancy, M. S. Wolff, R. A. Hiatt, M. Rivera, J. Vogelman, and N. Orentreich. 1994. “Breast Cancer and Serum Organochlorines: A Prospective Study Among White, Black, and Asian Women.” Journal of the National Cancer Institute 86:589–99.

    Article  Google Scholar 

  • Kuester, Gerald F., and Sidney M. Wolfe. 1991. “Health Research Group Report on Screening Mammography.” Public Citizen’s Health Research Group, Washington, D.C.

    Google Scholar 

  • Kushner, Rose. 1984. “Is Aggressive Adjuvant Chemotherapy the Halsted Radical of the ‘80s?” CA—A Cancer Journal for Clinicians 34:345–51.

    Article  Google Scholar 

  • Land, Charles, Masayoshi Tokunaga, Shoji Tokuoka, and Nori Nakamura. 1993. “Early-Onset Breast Cancer in A-Bomb Survivors.” Lancet 342:237.

    Article  Google Scholar 

  • Landis, Sarah H., Taylor Murray, Sherry Bolden, and Phyllis A. Wingo. 1999. “Cancer Statistics, 1999.” CA—A Cancer Journal for Clinicians 49:8–31.

    Article  Google Scholar 

  • Leopold, Ellen. 1998. “Not Every Picture Tells a Story.” Women’s Community Cancer Project Newsletter (Summer) 1–7.

    Google Scholar 

  • Love, Susan M., and Karen Lindsey. 1995. Dr. Susan Love’s Breast Book. New York: Addison-Wesley.

    Google Scholar 

  • MacKenzie, Ian. 1965. “Breast Cancer Following Multiple Fluoroscopies.” British Journal of Cancer 19:1–8.

    Article  Google Scholar 

  • Marsa, Linda. 1997. Prescription for Profits. New York: Charles Scribner.

    Google Scholar 

  • Marshall, Eliot. 1995. “NIH Gets a Share of BRCA1 Patent.” Science 267:1086.

    Article  Google Scholar 

  • Marwick, Charles. 1997. “NIH Consensus Panel Spurs Discontent.” Journal of the American Medical Association 277:519–20.

    Article  Google Scholar 

  • McKinlay, John B. and Sonja M. McKinlay 1997. “Medical Measures and the Decline of Mortality.” Pp. 10–23 in The Sociology of Health and Illness—Critical Perspectives, ed. P. Conrad. New York: St. Martin’s Press.

    Google Scholar 

  • McLelland, R. 1990. “Supply and Quality of Screening Mammography: A Radiologist’s View.” Annals of Internal Medicine 113:490–91.

    Article  Google Scholar 

  • Montague, Peter 1997. “Cancer Trends.” Rachel’s Environment and Health Weekly (July 12) 1–5.

    Google Scholar 

  • Moss, Ralph W. 1989. The Cancer Industry—Unraveling the Politics. New York: Paragon House.

    Google Scholar 

  • Moss, Ralph W. 1995. Questioning Chemotherapy. Brooklyn: Equinox Press.

    Google Scholar 

  • “Most Women Who Had Breasts Removed Had Cancer, Study Says.” 1977. Los Angeles Times (November 22) 1:7.

    Google Scholar 

  • Napoli, Maryann. 1994. “Misleading Ad Campaign by Mammography Clinics.” HealthFacts (April) 3.

    Google Scholar 

  • Napoli, Maryann. 1996. “Cancer Treatment: High Profits, Conflict of Interest, Little Efficacy.” HealthFacts (April) 1,4–5.

    Google Scholar 

  • Napoli, Maryann. 1999. “Breast Removal: The Latest in Cancer Prevention.” HealthFacts (February) 1–2.

    Google Scholar 

  • National Breast Cancer Coalition. 1999a. “15 Percent Increased Appropriations for Breast Cancer Research at the National Institutes of Health.” Washington, D.C.

    Google Scholar 

  • National Breast Cancer Coalition. 1999b. “$175 Million for the Department of Defense Peer-Reviewed Breast Cancer Research Program.” In Briefing Paper, Legislative Priority #1. Washington, D.C.

    Google Scholar 

  • National Cancer Institute. 1998. “Genetic Testing for Breast Cancer Risk: It’s Your Choice.” Washington, D.C.

    Google Scholar 

  • National Institutes of Health and American Society of Clinical Oncologists. 1999. “The Role of High-Dose Chemotherapy and Bone Marrow Transplant or Peripheral Stem-Cell Support in the Treatment of Breast Cancer.” At www.asco.org.

  • Okie, Susan. 1998. “FDA Panel Endorses Breast Cancer Drugs.” Washington Post (September 3) A3.

    Google Scholar 

  • Pasquier, Frank and Sophia Ku. 1997. “Mammography Services—Impact of Federal Legislation on Quality, Access, and Health Outcomes.” U.S. General Accounting Office, Washington, D.C.

    Google Scholar 

  • Paulsen, Monte. 1993. Nation (November 15) 557–58.

    Google Scholar 

  • Paulsen, Monte. 1994. “The Cancer Business.” Mother Jones (May–June) 41.

    Google Scholar 

  • Payer, Lynn. 1992. Disease-Mongers—How Doctors, Drug Companies, and Insurers Are Making You Feel Sick. New York: John Wiley.

    Google Scholar 

  • Plotkin, David 1996. “Good News and Bad News About Breast Cancer.” Atlantic Monthly (June) 53–82.

    Google Scholar 

  • Proctor, Robert N. 1995. Cancer Wars—How Politics Shape What We Know and Don’t Know About Cancer. New York: Basic Books.

    Google Scholar 

  • Reynolds, Tom. 1998. “Tamoxifen Debate Hinges on Whose Risk is High Enough.” Journal of the National Cancer Institute 90:1428–30.

    Article  Google Scholar 

  • Roush, Wade. 1997. “On the Biotech Pharm, A Race to Harvest New Cancer Cures.” Science 278:1039–40.

    Article  Google Scholar 

  • Shapiro, Renee 1998. “The Link Between Organochlorines and Breast Cancer—A Response.” Women’s Community Cancer Center Newsletter (Winter) 1,4–5.

    Google Scholar 

  • Sickles, Edward A. and Daniel B. Kopans. 1993. “Deficiencies in the Analysis of Breast Cancer Screening Data.” Journal of the National Cancer Institute 85:1621–24.

    Article  Google Scholar 

  • Skolnick, Andrew A. 1994. “Interim Federal Quality Standards for Nation’s Mammography Facilities Acquire Force of Law.” Journal of the American Medical Association 271:735–36.

    Article  Google Scholar 

  • Skolnick, Andrew A. 1995. “Leader in War on Cancer Looks Ahead.” Journal of the American Medical Association 273:525–27.

    Article  Google Scholar 

  • Smigel, Kara. 1995. “Women Flock to ABMT for Breast Cancer Without Final Proof.” Journal of the National Cancer Institute 87:952–55.

    Article  Google Scholar 

  • Sporn, Michael B. 1996. “The War on Cancer.” Lancet 347:1377–81.

    Article  Google Scholar 

  • Stauber, John and Sheldon Rampton. 1995. Toxic Sludge is Good for You!—Lies, Damn Lies and the Public Relations Industry. Monroe, Maine: Common Courage Press.

    Google Scholar 

  • Steinjudith A., Sarah A. Fox, and Paul J. Murata. 1991. “The Influence of Ethnicity, Socioeconomic Status, and Psychological Barriers on Use of Mammography.” Journal of Health and Social behavior 32:101–13.

    Article  Google Scholar 

  • Steingraber, Sandra. 1997. Living Downstream—An Ecologist Looks at Cancer and the Environment. New York: Addison-Wesley.

    Google Scholar 

  • Taubes, Gary. 1997. “The Breast-Screening Brawl.” Science 275:1056–59.

    Article  Google Scholar 

  • “Treatment Trouble: Zeneca Takes Over Salick Health Care.” 1997. Breast Cancer Action News (June/July) 1.

    Google Scholar 

  • Thornton, Joe. 1992. “Breast Cancer and the Environment: The Chlorine Connection.” Washington, D.C: Greenpeace.

    Google Scholar 

  • van Dam, Frits S. A. M., Sanne B. Schagen, Martin J. Muller, Willem Boogerd, Elsken v. d. Wall, Maria E. Droogleever Fortuyn, and Sjoerd Rodenhuis. 1998. “Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose versus Standard-Dose Chemotherapy.” Journal of the National Cancer Institute 90:210–18.

    Article  Google Scholar 

  • Weiss, Raymond B., Robert M. Rifkin, F. Marc Stewart, Richard L. Theriault, Lori A. Williams, Allen A. Herman, and Roy A. Beveridge. “High-Dose Chemotherapy for High-Risk Primary Breast Cancer: An On-Site Review of the Bezwoda Study.” Lancet 355:999–1003.

    Google Scholar 

  • Weiss, Rick. 1995. “How Goes the War on Cancer? Are Cases Going Up? Are Death Rates Going Down?” Washington Post (January 28) Z12.

    Google Scholar 

  • Welch, H. Gilbert and Elliott S. Fisher. 1998. “Diagnostic Testing Following Screening Mammography in the Elderly.” Journal of the National Cancer Institute 90:1389–92.

    Article  Google Scholar 

  • Wolff, M. S., P. G. Toniolo, E. W. Lee, L. M. Rivera, and N. Dubin. 1993. “Blood Levels of Organochlorine Residues and Risk of Breast Cancer.” Journal of the National Cancer Institute 85:648–52.

    Article  Google Scholar 

  • “Women Misdiagnosed with Breast Cancer.” 1983. National Women’s Health Network News (January/February) 5.

    Google Scholar 

Download references

Authors
  1. Jane S. Zones Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2000 Anne S. Kasper, Susan J. Ferguson

About this chapter

Cite this chapter

Zones, J.S. (2000). Profits from Pain: The Political Economy of Breast Cancer. In: Breast Cancer. Palgrave Macmillan, New York. https://doi.org/10.1007/978-1-137-03779-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-137-03779-4_5

  • Publisher Name: Palgrave Macmillan, New York

  • Print ISBN: 978-0-312-29451-9

  • Online ISBN: 978-1-137-03779-4

  • eBook Packages: Palgrave History CollectionHistory (R0)

Publish with us

Policies and ethics

Search

Navigation